GO
Loading...

Opsumit drug will be a growth driver: Actelion CEO

Tuesday, 22 Jul 2014 | 1:15 AM ET

Jean-Paul Clozel, CEO of Actelion, says its new drug Opsumit will be a strong driver of growth for the company.